New therapies in development for autoimmune diseases: their rationale for combination treatment
- PMID: 11455860
- DOI: 10.1007/s002810100071
New therapies in development for autoimmune diseases: their rationale for combination treatment
Similar articles
-
[New therapeutic approaches to autoimmune diseases].Presse Med. 2006 Apr;35(4 Pt 2):709-13. doi: 10.1016/s0755-4982(06)74667-x. Presse Med. 2006. PMID: 16614619 Review. French.
-
B-cell depletion in autoimmune diseases. Advances in autoimmunity.Autoimmun Rev. 2009 Jun;8(7):585-90. doi: 10.1016/j.autrev.2009.02.003. Epub 2009 Feb 10. Autoimmun Rev. 2009. PMID: 19393204
-
Anticytokine therapy impacting on B cells in autoimmune diseases.Curr Opin Rheumatol. 2009 May;21(3):205-10. doi: 10.1097/BOR.0b013e32832a0760. Curr Opin Rheumatol. 2009. PMID: 19346949 Review.
-
[Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases].Orv Hetil. 2005 Apr 3;146(14):635-43. Orv Hetil. 2005. PMID: 15889537 Review. Hungarian.
-
Immunoglobulins on the surface of lymphocytes in autoimmune disease. II. Lymphocytotoxins on the surface of lymphocytes.Acta Med Acad Sci Hung. 1974;31(1-2):115-8. Acta Med Acad Sci Hung. 1974. PMID: 4549467 No abstract available.
Cited by
-
Autoimmune disorders: a concept of treatment based on mechanisms of disease.Springer Semin Immunopathol. 2003 Dec;25 Suppl 1:S5-S60. doi: 10.1007/s00281-003-0151-1. Epub 2003 Nov 6. Springer Semin Immunopathol. 2003. PMID: 14655023 Review. No abstract available.
-
Immunosuppression by co-stimulatory molecules: inhibition of CD2-CD48/CD58 interaction by peptides from CD2 to suppress progression of collagen-induced arthritis in mice.Chem Biol Drug Des. 2013 Jul;82(1):106-18. doi: 10.1111/cbdd.12138. Chem Biol Drug Des. 2013. PMID: 23530775 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical